论文部分内容阅读
Improved detection of small-sized hepatic metastases using PSF and TOF: phantom and clinical studies
【机 构】
：
Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo,Japan
【出 处】
：
2nd Asian Nuclear Medicine Academic Forum & 3rd Rising NM Pr
【发表日期】
：
2016年8期
其他文献
Background: Ethambutol labeled 99mTc-pertechnetate (99mTc-Ethambutol) will be spesifically uptake by Mycobacterium tuberculosis(M.tuberculosis),so its can be use to detect tuberculosis lesion.
The usefulness of thyroglobulin doubling time to determine optimal timing to initiate Lenvatinib the
Background: Early initiation of Lenvatinib in radioactive-iodine-refractory differentiated thyroid cancer (RR-DTC) patients improves prognosis,but initiating Lenvatinib too early burdens patients unne
Lymphatic filariasis (LF) is a parasitic disease caused by thin,thread-like filarial worms transmitted to humans by the bite of mosquitoes.
Quantitative Parameters in Tc-99m Pertechnetate Thyroid Scintigraphy Predicts Increased Gland Uptake
Background: Direct measurement of gland uptake function is done by determining radioactive iodine uptake values.Thyroid hormone levels however have supplanted RAI uptake in the diagnosis of hyperthyro
Influences of different processing methods of SPECT on functional indicators of myocardial perfusion
会议
Determination of Metabolites and Processes Related Impurities for Radiomedicines by HPLC-Tandem Mass
RadioPharmaceutical Characterization Laboratory (RPCL) of Institute of Nuclear Energy Research (INER) has been devoting to develop chemical analysis and identification of structures techniques based o
Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown
Objective: Carcinoma of unknown primary (CUP) represents a heterogeneous group of metastatic malignancies for which primary tumor site could not be identified after routine diagnostic methods.
Background: During the past half century,rapid advances in biomedical technology,especially with regards to imaging,have revolutionized the approach to diagnosis and treatment of diseases.
Thyroid Hormone Replacement before I-131 Therapy in Patients with Well-differentiated Thyroid Cancer
Background: Radioiodine-131 (I-131) tiherapy has been commonly used for well differentiated thyroid cancer (DTC).To achieve sufficient I-131 uptake in residual thyroid tissues and tumors,I-131 therapy